Breaking News Instant updates and real-time market news.

TYME

Tyme Technologies

$2.13

-0.05 (-2.29%)

08:02
04/06/18
04/06
08:02
04/06/18
08:02

Tyme Technologies, JAF announce sarcoma treatment collaboration

Tyme Technologies announced that it is collaborating with The Joseph Ahmed Foundation to provide treatment for metastatic sarcomas. The collaboration will focus on children and young adults with bone or soft tissue sarcomas, with an initial focus on Ewing's sarcoma. Sarcomas are rare forms of cancer that have poor prognosis at the metastatic stage, with most treatment options demonstrating limited efficacy and high toxicity. Two Ewing's sarcoma patients have previously been treated with Tyme's SM-88 therapy under compassionate use programs, both of whom achieved a complete or partial response with no drug-related severe adverse events. Under this new collaboration, Tyme will supply SM-88 at no cost and JAF will provide resources for physicians to perform investigator-sponsored trials. JAF and Tyme will be also participating in the April 2018 New Jersey marathon in honor of Joe's Cure Walk and to raise money for sarcoma research.

TYME Tyme Technologies
$2.13

-0.05 (-2.29%)

12/15/17
HCWC
12/15/17
INITIATION
Target $8
HCWC
Buy
Tyme Technologies initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Tyme Technologies with a Buy rating and $8 price target. With a potential first-in-class clinical asset for end-stage cancer and several upcoming near-term catalysts, Tyme is an underappreciated oncology play, the analyst contends.
01/03/18
ADAM
01/03/18
INITIATION
Target $10
ADAM
Buy
Tyme Technologies initiated with a Buy at Canaccord
Canaccord analyst Arlinda Lee started Tyme Technologies with a Buy rating and a $10 price target, saying he views the ability of Tyme's SM-88 to generate responses in advanced cancer patients with durable effect across a range of solid and liquid tumors as "intriguing."
01/04/18
01/04/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Buy at Buckingham. 2. Tyme Technologies (TYME) initiated with a Buy at Canaccord. 3. Visteon (VC) initiated with a Buy at Guggenheim. 4. Core-Mark (CORE) initiated with an Outperform at William Blair. 5. PJT Partners (PJT) initiated with a Neutral at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/08/18
HCWC
02/08/18
NO CHANGE
Target $9.5
HCWC
Buy
Tyme Technologies price target raised to $9.50 from $8 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Tyme Technologies to $9.50 citing recent changes to U.S. tax code. The analyst believes the company's pancreatic and prostate programs are on track and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

MDGS

Medigus

$2.95

-0.09 (-2.96%)

07:18
11/20/18
11/20
07:18
11/20/18
07:18
Hot Stocks
Medigus to form new company for mini video cameras »

Medigus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AB

AllianceBernstein

$29.28

-0.37 (-1.25%)

07:17
11/20/18
11/20
07:17
11/20/18
07:17
Hot Stocks
AllianceBernstein announces offer to acquire Autonomous Research »

AllianceBernstein and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$25.24

-0.14 (-0.55%)

, IBM

IBM

$120.37

-1.23 (-1.01%)

07:16
11/20/18
11/20
07:16
11/20/18
07:16
Hot Stocks
Nielsen names David Kenny as CEO, effective December 3 »

The Board of Directors of…

NLSN

Nielsen

$25.24

-0.14 (-0.55%)

IBM

IBM

$120.37

-1.23 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 03

    Mar

GMDA

Gamida Cell

$9.50

-0.48 (-4.81%)

07:16
11/20/18
11/20
07:16
11/20/18
07:16
Initiation
Gamida Cell initiated  »

Gamida Cell initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

CODI

Compass Diversified

$15.11

-0.11 (-0.72%)

07:15
11/20/18
11/20
07:15
11/20/18
07:15
Conference/Events
Compass Diversified management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

  • 28

    Nov

07:15
11/20/18
11/20
07:15
11/20/18
07:15
General news
FX Update: There have been mixed themes »

FX Update: There have…

AAPL

Apple

$185.80

-7.62 (-3.94%)

07:14
11/20/18
11/20
07:14
11/20/18
07:14
Recommendations
Apple analyst commentary  »

Apple price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

STML

Stemline

$10.61

-0.76 (-6.68%)

07:14
11/20/18
11/20
07:14
11/20/18
07:14
Hot Stocks
Stemline announces EMA grants accelerated assessment for Elzonris MAA »

Stemline announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

  • 21

    Feb

NJR

New Jersey Resources

$50.16

0.39 (0.78%)

07:12
11/20/18
11/20
07:12
11/20/18
07:12
Earnings
New Jersey Resources sees FY19 NFE $1.95-$2.05 »

NJR expects its regulated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BECN

Beacon Roofing

$27.74

0.12 (0.43%)

07:11
11/20/18
11/20
07:11
11/20/18
07:11
Recommendations
Beacon Roofing analyst commentary  »

Beacon Roofing price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NJR

New Jersey Resources

$50.16

0.39 (0.78%)

07:10
11/20/18
11/20
07:10
11/20/18
07:10
Earnings
New Jersey Resources reports Q4 EPS (18c), consensus (44c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BKI

Black Knight

$45.54

-4.23 (-8.50%)

07:09
11/20/18
11/20
07:09
11/20/18
07:09
Recommendations
Black Knight analyst commentary  »

Black Knight price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

CELC

Celcuity

$24.00

-0.7 (-2.83%)

07:08
11/20/18
11/20
07:08
11/20/18
07:08
Initiation
Celcuity initiated  »

Celcuity initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLS

Apellis

$14.38

-0.72 (-4.77%)

, BIIB

Biogen

$319.15

-4.86 (-1.50%)

07:08
11/20/18
11/20
07:08
11/20/18
07:08
Hot Stocks
Apellis appoints Adam Townsend as CCO »

Apellis (APLS) announced…

APLS

Apellis

$14.38

-0.72 (-4.77%)

BIIB

Biogen

$319.15

-4.86 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

BBY

Best Buy

$62.19

-4.22 (-6.35%)

07:07
11/20/18
11/20
07:07
11/20/18
07:07
Earnings
Best Buy sees Q4 EPS $2.48-$2.58, consensus $2.58 »

Sees Q4 Enterprise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

CLBS

Caladrius

$4.70

-0.18 (-3.69%)

07:06
11/20/18
11/20
07:06
11/20/18
07:06
Initiation
Caladrius initiated  »

Caladrius assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$62.19

-4.22 (-6.35%)

07:05
11/20/18
11/20
07:05
11/20/18
07:05
Earnings
Best Buy raises FY19 EPS view to $5.09-$5.19 from $4.95-$5.10 »

Consensus $5.11. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

RNSDF

Renault

$0.00

(0.00%)

, NSANY

Nissan

$0.00

(0.00%)

07:05
11/20/18
11/20
07:05
11/20/18
07:05
Periodicals
Renault board to discuss interim replacement for Ghosn, Reuters reports »

The board of French…

RNSDF

Renault

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OASM

Oasmia

$4.30

-0.64 (-12.96%)

07:05
11/20/18
11/20
07:05
11/20/18
07:05
Hot Stocks
Oasmia announces notice of allowance for nanotech patent from USPTO »

Oasmia announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$70.75

-1.73 (-2.39%)

07:04
11/20/18
11/20
07:04
11/20/18
07:04
Earnings
Kohl's narrows FY18 EPS view to $4.35-$5.55 from $5.15-$5.55, consensus $5.51 »

Kohl's is raising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CTT

CatchMark Timber

$9.15

0.005 (0.05%)

07:03
11/20/18
11/20
07:03
11/20/18
07:03
Initiation
CatchMark Timber initiated  »

CatchMark Timber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$0.64

-0.0259 (-3.87%)

07:03
11/20/18
11/20
07:03
11/20/18
07:03
Hot Stocks
BioLineRx receives Biological Product Designation for AGI-134 from FDA »

BioLineRx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$62.19

-4.22 (-6.35%)

07:03
11/20/18
11/20
07:03
11/20/18
07:03
Earnings
Best Buy reports Q3 EPS 93c, consensus 85c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

ODP

Office Depot

$2.94

-0.165 (-5.32%)

07:02
11/20/18
11/20
07:02
11/20/18
07:02
Hot Stocks
Office Depot authorizes new $100M stock repurchase program »

Office Depot's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$70.75

-1.73 (-2.39%)

07:02
11/20/18
11/20
07:02
11/20/18
07:02
Earnings
Kohl's reports Q3 EPS 98c, consensus 96c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.